The Department of Defense has awarded Profectus BioSciences Inc., of Baltimore, a pharmaceutical company, a $9.5 million contract for manufacture and testing of Profectus' prospective Ebola vaccine, the company announced Friday. "While the urgent need today is for a vaccine that protects against the current Ebola Zaire outbreak, we are also anticipating the needs for tomorrow.
http://ift.tt/1q9MPHL
http://ift.tt/1q9MPHL
No comments:
Post a Comment